TENX Tenax Therapeutics, Inc.
Fundamentals / CIK 0000034956 / USDTenax Therapeutics, Inc. reported $0 in revenue and a net loss of $65.76M for the trailing twelve months ended September 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TENX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2026
-
Operating Income TTM-$69.53M Operating profit
-
Net Income TTM-$65.76M GAAP bottom line
-
Diluted EPS TTM-$1.23 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$113.7M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | $0 |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $32.67M | $12.71M | $3.23M | $5.38M | $25.15M | $4.56M | $3.47M | $1.24M | $3.53M | $13.14M |
| Selling, General & Admin | -- | -- | -- | -- | $7.58M | $5.31M | $5.08M | $5.65M | $5.68M | $6.25M |
| Total Operating Expenses | $56.38M | $19.49M | $8.23M | $11.05M | $32.73M | $9.87M | $8.56M | $6.89M | $9.21M | $52.65M |
| Operating Income | -$56.38M | -$19.49M | -$8.23M | $11.05M | -$32.73M | $9.87M | -$8.56M | -$6.89M | -$9.21M | -$52.65M |
| EBITDA | -- | -$19.49M | -$8.23M | $11.06M | -$32.72M | $9.87M | -$8.55M | -$6.88M | -$9.19M | -$52.63M |
| Interest Expense | $0 | $23K | $24K | $4.4K | $949 | $1.6K | $0 | -- | -- | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$7.96M |
| Net Income | -$52.60M | -$17.60M | -$7.71M | $11.05M | -$32.47M | -$9.85M | -$8.39M | -$14.14M | -$8.84M | -$43.92M |
| Basic EPS | -$1.34 | -$1.15 | -$31.04 | -- | -$1.58 | -$0.95 | -$1.35 | -$9.04 | -$6.27 | -$31.24 |
| Diluted EPS | -$1.34 | -$1.15 | -$31.04 | -- | -$1.58 | -$0.95 | -$1.35 | -$9.04 | -$6.27 | -$31.24 |
| Basic Shares Outstanding | 39.2M | 15.3M | 248.4K | -- | 20.6M | 10.4M | 6.2M | 1.6M | 1.4M | 1.4M |
| Diluted Shares Outstanding | 39.2M | 15.3M | 248.4K | -- | 20.6M | 10.4M | 6.2M | 1.6M | 1.4M | 1.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Research & Development | $12.07M | $12.85M | $11.54M | $10.54M | $10.33M | $6.12M | $5.68M | $4.59M |
| Selling, General & Admin | $5.66M | $5.93M | -- | -- | $6.48M | $5.67M | -- | -- |
| Total Operating Expenses | $17.73M | $18.78M | $16.57M | $16.45M | $16.81M | $11.79M | $11.34M | $7.29M |
| Operating Income | -$17.73M | -$18.78M | -$16.57M | -$16.45M | -$16.81M | -$11.79M | -$11.34M | -$7.29M |
| EBITDA | -- | -- | -- | -- | -- | -- | -- | -$7.29M |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | -$1.0K |
| Net Income | -$16.70M | -$17.80M | -$15.72M | -$15.54M | -$15.80M | -$10.85M | -$10.41M | -$6.27M |
| Basic EPS | -$0.31 | -$0.35 | -$0.35 | -- | -$0.40 | -$0.27 | -$0.28 | -- |
| Diluted EPS | -$0.31 | -$0.35 | -$0.35 | -- | -$0.40 | -$0.27 | -$0.28 | -- |
| Basic Shares Outstanding | 53.5M | 50.9M | 45.2M | -- | 39.7M | 39.6M | 36.6M | -- |
| Diluted Shares Outstanding | 53.5M | 50.9M | 45.2M | -- | 39.7M | 39.6M | 36.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $97.60M | $94.90M | $9.80M | $2.12M | $5.58M | $6.25M | $4.91M | $12.37M | $1.60M | $10.00M |
| Short-Term Investments | -- | -- | -- | -- | $0 | $463K | $494K | $495K | $6.12M | $3.28M |
| Cash & Short-Term Investments | $97.60M | $94.90M | $9.80M | $2.12M | $5.58M | $6.71M | $5.40M | $12.86M | $7.73M | $13.28M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 | $50K | $73K |
| Other Current Assets | $1.02M | $64K | $252K | $346K | $0 | -- | -- | -- | -- | -- |
| Total Current Assets | $104.2M | $96.69M | $11.68M | $3.21M | $5.69M | $6.80M | $6.18M | $13.32M | $8.06M | $13.63M |
| Property, Plant & Equipment, Net | -- | -- | $0 | $7.2K | $7.1K | $6.0K | $6.6K | $8.5K | $9.9K | $19K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $0 | $1.81M | $8.59M |
| Other Non-Current Assets | -- | $0 | $1.0K | $9.6K | $8.4K | $8.4K | $8.4K | $8.4K | $8.4K | $1.11M |
| Total Non-Current Assets | $0 | $0 | $1.0K | $196K | $303K | $73K | $184K | $17K | $1.83M | $9.71M |
| Total Assets | $104.2M | $96.69M | $11.69M | $3.40M | $5.99M | $6.87M | $6.37M | $13.34M | $9.89M | $23.34M |
| Accounts Payable | $6.04M | $3.16M | $2.07M | $448K | $860K | $758K | $1.66M | $750K | $612K | $728K |
| Total Current Liabilities | $7.16M | $4.69M | $3.59M | $1.85M | $1.56M | $2.12M | $2.53M | $1.57M | $1.01M | $6.20M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $64K | $184K | $124K | $60K | $0 | $0 | $0 |
| Total Liabilities | $7.16M | $4.69M | $3.59M | $1.91M | $1.75M | $2.24M | $2.59M | $1.57M | $1.01M | $6.20M |
| Total Debt (incl. Leases) | -- | -- | -- | $184K | $291K | $60K | $172K | -- | -- | -- |
| Common Stock | $1.0K | $0 | $0 | $3 | $2.5K | $0 | $674 | $379 | $141 | $2.8K |
| Retained Earnings | -$367.5M | -$314.9M | -$297.3M | -$289.5M | -$278.5M | -$246.0M | -$236.2M | -$227.8M | -$213.5M | -$204.7M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | -$70 | $458 | $516 | -$16K | -$19K |
| Total Stockholders' Equity | $97.07M | $91.99M | $8.10M | $1.49M | $4.24M | $4.63M | $3.77M | $11.77M | $8.88M | $17.14M |
| Total Equity | $97.07M | $91.99M | $8.10M | $1.49M | $4.24M | $4.63M | $3.77M | $11.77M | $8.88M | $17.14M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $113.7M | $118.0M | $118.8M | $97.60M | $99.40M | $105.5M | $111.4M | $94.90M |
| Cash & Short-Term Investments | $113.7M | $118.0M | $118.8M | $97.60M | $99.40M | $105.5M | $111.4M | $94.90M |
| Other Current Assets | $108K | $272K | $107K | $1.02M | -- | -- | $88K | $64K |
| Total Current Assets | $117.0M | $121.7M | $123.2M | $104.2M | $102.8M | $105.9M | $112.1M | $96.69M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $117.0M | $121.7M | $123.2M | $104.2M | $102.8M | $105.9M | $112.1M | $96.69M |
| Accounts Payable | $6.57M | $6.79M | $6.35M | $6.04M | $5.61M | $562K | $1.84M | $3.16M |
| Total Current Liabilities | $8.36M | $8.07M | $8.49M | $7.16M | $6.60M | $2.53M | $2.77M | $4.69M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.36M | $8.07M | $8.49M | $7.16M | $6.60M | $2.53M | $2.77M | $4.69M |
| Common Stock | $5.0K | $3.0K | $2.0K | $1.0K | $1.0K | $0 | $0 | $0 |
| Retained Earnings | -$417.7M | -$401.0M | -$383.2M | -$367.5M | -$351.9M | -$336.1M | -$325.3M | -$314.9M |
| Total Stockholders' Equity | $108.7M | $113.6M | $114.7M | $97.07M | $96.21M | $103.3M | $109.3M | $91.99M |
| Total Equity | $108.7M | $113.6M | $114.7M | $97.07M | $96.21M | $103.3M | $109.3M | $91.99M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$52.60M | -$17.60M | -$7.71M | -$11.05M | -$32.47M | $9.85M | -$8.39M | -$14.14M | -$8.84M | -$43.92M |
| Depreciation & Amortization | -- | $0 | $8.0K | $5.1K | $4.1K | $4.1K | $5.0K | $9.0K | $14K | $19K |
| Stock-Based Compensation | $19.16M | $1.12M | $191K | -- | -- | -- | $0 | $190K | $80K | $1.1K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | $2.88M | $1.06M | $1.65M | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow | -$35.80M | -$14.81M | -$5.90M | -$11.39M | -$10.86M | -$9.27M | -$7.56M | -$5.50M | -$12.14M | -$15.87M |
| Capital Expenditure | -- | -- | -- | -$2.3K | -$5.3K | -$3.5K | -$3.6K | -$7.6K | -$4.5K | -$2.9K |
| Free Cash Flow | -- | -- | -- | -$11.39M | -$10.86M | -$9.28M | -$7.56M | -$5.51M | -$12.15M | -$15.87M |
| Purchases of Investments | -- | -- | -- | $0 | -$346K | -$597K | -$618K | -$494K | -$299K | -$7.26M |
| Investing Cash Flow | -- | $0 | $3.0K | -$2.3K | $453K | $20K | -$1.7K | $7.35M | $3.75M | $22.21M |
| Common Stock Issued | -- | -- | -- | -- | $9.19M | $8.66M | $0 | -- | -- | $0 |
| Financing Cash Flow | $38.51M | $99.87M | $13.57M | $7.93M | $9.74M | $10.60M | $96K | $8.91M | $0 | $0 |
| Net Change in Cash | $2.71M | $85.06M | $7.67M | -$3.46M | -$666K | $1.34M | -$7.46M | $10.76M | -$8.39M | $6.34M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$16.70M | -$17.80M | -$15.72M | -$15.54M | -$15.80M | -$10.85M | -$10.41M | -$6.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | $3.54M | $3.33M | $2.84M | $4.79M | $5.62M | $4.61M | $4.14M | $970K |
| Change in Payables | -$225K | $449K | $305K | $432K | $5.05M | -$1.28M | -$1.32M | $1.57M |
| Operating Cash Flow | -$12.48M | -$14.15M | -$9.31M | -$13.41M | -$9.15M | -$6.26M | -$6.97M | -$3.53M |
| Investing Cash Flow | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $8.23M | $13.37M | $30.50M | $11.61M | $3.06M | $278K | $23.56M | $67K |
| Net Change in Cash | -$4.25M | -$779K | $21.19M | -$1.80M | -$6.09M | -$5.99M | $16.60M | -$3.46M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -54.2% | -19.1% | -95.2% | 740.0% | -765.1% | -213.0% | -222.5% | -120.2% | -99.5% | -256.3% |
| Return on Assets (ROA) | -50.5% | -18.2% | -66.0% | 324.5% | -541.9% | -143.4% | -131.9% | -106.0% | -89.4% | -188.2% |
| Current Ratio | 14.56x | 20.60x | 3.26x | 1.74x | 3.64x | 3.21x | 2.44x | 8.51x | 7.99x | 2.20x |
| Quick Ratio | 13.64x | 20.22x | 2.73x | 1.15x | 3.57x | 3.17x | 2.13x | 8.21x | 7.71x | 2.15x |
| Debt to Equity | -- | -- | -- | 0.12x | 0.07x | 0.01x | 0.05x | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -174.5% | -- | -431.7% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -169.8% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -60.5% | -57.1% | -50.5% | -54.2% | -45.0% | -30.5% | -22.2% | -19.1% |
| Return on Assets (ROA) | -56.2% | -53.3% | -47.0% | -50.5% | -42.1% | -29.7% | -21.6% | -18.2% |
| Current Ratio | 14.01x | 15.07x | 14.52x | 14.56x | 15.58x | 41.89x | 40.48x | 20.60x |
| Quick Ratio | 13.61x | 14.62x | 14.00x | 13.64x | 15.06x | 41.75x | 40.25x | 20.22x |